IMI Members

EU Logo efpia logo

Factsheets for IMI projects

The Innovative Medicines Initiative (IMI) now has 23 projects that are up and running as a result of the successful launches of its 1st and 2nd Calls.

IMI Education & Training Projects

All Projects

- BTCure

Be The Cure

- DDMoRe

Drug Disease Model Resources     

- EHR4CR

Electronic Health Records Systems for Clinical Research

- EMTRAIN

European Medicines Research Training Network  

- eTOX

Integrating bioinformatics and chemoinformatics approaches for the development of Expert systems allowing the in silico prediction of toxicities  

- Eu2P

European programme in Pharmacovigilance and Pharmacoepidemiology

- EUROPAIN

Understanding chronic pain and improving its treatment

- IMIDIA

Improving beta-cell function and identification of diagnostic biomarkers For treatment monitoring in diabetes

- MARCAR

Biomarkers and molecular tumour classification for non-genotoxic carcinogenesis

- NEWMEDS

Novel methods leading to new medications in depression and schizophrenia

- Onco Track

Methods for systematic next generation oncology biomarker development

- Open PHACTS

The Open Pharmacological Concepts Triple Store

- Pharma-Cog

Prediction of cognitive properties of new drug candidates For neurodegenerative diseases in early clinical development  

- Pharmatrain

Pharmaceutical Medicine Training Programme

- Predect

New models for preclinical evaluation of drug efficacy in common solid tumours  

- PRO-active

Physical Activity as a Crucial Patient Reported Outcome in COPD

- PROTECT

Pharmacoepidemiiological research on outcomes Of therapeutics by a european consortium  

- Quic-Concept

Quantative imaging in cancer:connecting cellular process with therapy    

- RAPP-ID

Development of rapid point-of-care test platforms for infectious diseases  

- SAFE-T

Safer and Faster Evidence-based Translation

- SafeSciMET

European Modular Education and Training Programme in Safety Sciences for Medicines

- SUMMIT

Surrogate markers for micro- and macro-vascular hard endpoints for innovative diabetes tools

- U-BIOPRED

Unbiased biomarkers for the prediction of respiratory disease outcomes